Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Court Grants Natera Injunction Against Invitae, ArcherDx in Use of Patented Products
The defendants are barred from using Personalized Cancer Monitoring products except for ongoing clinical trials, studies undergoing peer review, and quality control.
Investigational Cancer Drug Deemed Highly Mutagenic in Cell Line Sequencing Study
Using whole-genome sequencing on drug-exposed cell lines, researchers saw high mutation rates in control cell lines intermittently treated with a compound called CX-5461.
Claris GenomiX Seeks Commercialization Partners for Cancer Subtyping Tests, Starting With CRC
Premium
The University of Notre Dame spinout has developed molecular subtyping tests for colorectal and other cancers, and seeks partners to bring them to the clinic.
Burning Rock Biotech Q3 Revenues Down 18 Percent
Falling central laboratory testing services drove the revenue downturn as the firm continues to shift focus to its in-hospital testing business.
Thermo Fisher Scientific, Pfizer Canada Grant C$300K to Study NGS in Colorectal Cancer Care
The recipients of both grants will study the effects of bringing next-generation sequencing-based testing into a community cancer center.